Bruce Jackson
Stock Analyst at Benchmark
(0.82)
# 2,867
Out of 4,413 analysts
76
Total ratings
20.51%
Success rate
-19.36%
Average return
Main Sectors:
23 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NEO NeoGenomics | Reiterates: Buy | $18 | $13.59 | +32.45% | 4 | May 1, 2024 | |
| CDIO Cardio Diagnostics Holdings | Maintains: Speculative Buy | $4 → $1.35 | $0.67 | +101.49% | 3 | Apr 19, 2024 | |
| RVPH Reviva Pharmaceuticals Holdings | Reiterates: Speculative Buy | $17 | $3.19 | +432.92% | 2 | Apr 16, 2024 | |
| TNON Tenon Medical | Maintains: Speculative Buy | $5 → $3 | $0.76 | +294.74% | 2 | Apr 15, 2024 | |
| OCX OncoCyte | Reiterates: Speculative Buy | $5 | $2.50 | +100.00% | 3 | Apr 15, 2024 | |
| UNCY Unicycive Therapeutics | Reiterates: Speculative Buy | $3 | $1.12 | +167.86% | 4 | Apr 15, 2024 | |
| KNW Know Labs | Initiates: Speculative Buy | $1 | $0.65 | +53.85% | 1 | Apr 8, 2024 | |
| GNLX Genelux | Reiterates: Speculative Buy | $30 | $3.18 | +843.40% | 4 | Apr 3, 2024 | |
| HUMA Humacyte | Reiterates: Buy | $15 | $4.16 | +261.01% | 5 | Mar 25, 2024 | |
| BIOL BIOLASE | Maintains: Speculative Buy | $2.5 → $0.4 | $0.14 | +176.05% | 2 | Mar 22, 2024 | |
| MODD Modular Medical | Reiterates: Speculative Buy | $5 | $1.55 | +222.58% | 4 | Mar 21, 2024 | |
| CLNN Clene | Reiterates: Buy | $5 | $0.42 | +1,095.89% | 5 | Mar 20, 2024 | |
| EXAS Exact Sciences | Upgrades: Buy | $91 | $58.12 | +56.57% | 4 | Jan 2, 2024 | |
| GDTC CytoMed Therapeutics | Reiterates: Speculative Buy | $5 | $2.20 | +127.27% | 2 | Dec 4, 2023 | |
| SKIN The Beauty Health Company | Downgrades: Hold | n/a | $3.19 | - | 7 | Nov 14, 2023 | |
| BLTE Belite Bio | Reiterates: Buy | $57 | $40.78 | +39.79% | 5 | Nov 7, 2023 | |
| SEEL Seelos Therapeutics | Maintains: Speculative Buy | $120 → $30 | $0.28 | +10,482.01% | 3 | Sep 21, 2023 | |
| STAA STAAR Surgical Company | Downgrades: Hold | n/a | $45.30 | - | 4 | Sep 15, 2023 | |
| BFRI Biofrontera | Reiterates: Buy | $18 | $1.97 | +813.71% | 5 | Aug 31, 2023 | |
| HBIO Harvard Bioscience | Reiterates: Speculative Buy | $7 | $3.81 | +83.73% | 3 | Jun 22, 2023 | |
| HOTH Hoth Therapeutics | Reiterates: Speculative Buy | $5 | $1.23 | +306.50% | 2 | Jun 20, 2023 | |
| VNRX VolitionRx | Downgrades: Hold | n/a | $0.89 | - | 1 | Feb 1, 2023 | |
| HSCS Heart Test Laboratories | Initiates: Speculative Buy | $8 | $0.09 | +8,662.32% | 1 | Aug 8, 2022 |
NeoGenomics
May 1, 2024
Reiterates: Buy
Price Target: $18
Current: $13.59
Upside: +32.45%
Cardio Diagnostics Holdings
Apr 19, 2024
Maintains: Speculative Buy
Price Target: $4 → $1.35
Current: $0.67
Upside: +101.49%
Reviva Pharmaceuticals Holdings
Apr 16, 2024
Reiterates: Speculative Buy
Price Target: $17
Current: $3.19
Upside: +432.92%
Tenon Medical
Apr 15, 2024
Maintains: Speculative Buy
Price Target: $5 → $3
Current: $0.76
Upside: +294.74%
OncoCyte
Apr 15, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $2.50
Upside: +100.00%
Unicycive Therapeutics
Apr 15, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $1.12
Upside: +167.86%
Know Labs
Apr 8, 2024
Initiates: Speculative Buy
Price Target: $1
Current: $0.65
Upside: +53.85%
Genelux
Apr 3, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $3.18
Upside: +843.40%
Humacyte
Mar 25, 2024
Reiterates: Buy
Price Target: $15
Current: $4.16
Upside: +261.01%
BIOLASE
Mar 22, 2024
Maintains: Speculative Buy
Price Target: $2.5 → $0.4
Current: $0.14
Upside: +176.05%
Modular Medical
Mar 21, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $1.55
Upside: +222.58%
Clene
Mar 20, 2024
Reiterates: Buy
Price Target: $5
Current: $0.42
Upside: +1,095.89%
Exact Sciences
Jan 2, 2024
Upgrades: Buy
Price Target: $91
Current: $58.12
Upside: +56.57%
CytoMed Therapeutics
Dec 4, 2023
Reiterates: Speculative Buy
Price Target: $5
Current: $2.20
Upside: +127.27%
The Beauty Health Company
Nov 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $3.19
Upside: -
Belite Bio
Nov 7, 2023
Reiterates: Buy
Price Target: $57
Current: $40.78
Upside: +39.79%
Seelos Therapeutics
Sep 21, 2023
Maintains: Speculative Buy
Price Target: $120 → $30
Current: $0.28
Upside: +10,482.01%
STAAR Surgical Company
Sep 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $45.30
Upside: -
Biofrontera
Aug 31, 2023
Reiterates: Buy
Price Target: $18
Current: $1.97
Upside: +813.71%
Harvard Bioscience
Jun 22, 2023
Reiterates: Speculative Buy
Price Target: $7
Current: $3.81
Upside: +83.73%
Hoth Therapeutics
Jun 20, 2023
Reiterates: Speculative Buy
Price Target: $5
Current: $1.23
Upside: +306.50%
VolitionRx
Feb 1, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.89
Upside: -
Heart Test Laboratories
Aug 8, 2022
Initiates: Speculative Buy
Price Target: $8
Current: $0.09
Upside: +8,662.32%